Jidapa Jitta

Dhurakijpundit University - Kitakyushu / Thailand

Others

AD Scientific Index ID: 4303700

มหาวิทยาลัยธุรกิจบัณฑิตย์

Registration, Add Profile,
Premium Membership

Print Your Certificate

Jidapa Jitta's MOST POPULAR ARTICLES

1-) Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid …M Schiff, M Keiserman, C Codding, S Songcharoen, A Berman, ...Annals of the rheumatic diseases 67 (8), 1096-1103, 20086372008

2-) Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase …R Fleischmann, E Mysler, S Hall, AJ Kivitz, RJ Moots, Z Luo, R DeMasi, ...The Lancet 390 (10093), 457-468, 20173572017

3-) Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST StudyM Schiff, M Keiserman, C Codding, S Songcharoen, A Berman, ...Annals of the rheumatic diseases 70 (11), 2003-2007, 2011652011

4-) Inflammatory arthritis and subcutaneous fat necrosis associated with acute and chronic pancreatitisRP Macon Jr, RE Sulser, S SongcharoenArthritis & Rheumatism: Official Journal of the American College of …, 1980431980

5-) Long-Term Safety of Rituximab in Rheumatoid Arthritis: Analysis From the SUNSTONE Registry.KL Winthrop, K Saag, MD Cascino, J Pei, A John, A Jahreis, T Haselkorn, ...Arthritis care & research, 201838*2018

ARTICLES

Add your articles